581 Shares in McKesson Co. (NYSE:MCK) Bought by Ameriflex Group Inc.

Ameriflex Group Inc. purchased a new position in shares of McKesson Co. (NYSE:MCK - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 581 shares of the company's stock, valued at approximately $346,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Cibc World Market Inc. lifted its position in McKesson by 6.3% during the 4th quarter. Cibc World Market Inc. now owns 20,252 shares of the company's stock worth $11,542,000 after acquiring an additional 1,207 shares during the period. Brentview Investment Management LLC acquired a new position in McKesson in the 4th quarter valued at $3,018,000. Ingalls & Snyder LLC raised its position in McKesson by 8.2% during the 4th quarter. Ingalls & Snyder LLC now owns 13,824 shares of the company's stock worth $7,878,000 after buying an additional 1,047 shares during the last quarter. Chicago Partners Investment Group LLC lifted its stake in shares of McKesson by 85.0% in the 4th quarter. Chicago Partners Investment Group LLC now owns 1,262 shares of the company's stock worth $745,000 after acquiring an additional 580 shares during the period. Finally, Blue Trust Inc. boosted its holdings in shares of McKesson by 6.4% in the fourth quarter. Blue Trust Inc. now owns 7,830 shares of the company's stock valued at $4,462,000 after acquiring an additional 468 shares in the last quarter. 85.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on MCK. UBS Group lifted their price objective on McKesson from $708.00 to $805.00 and gave the company a "buy" rating in a report on Tuesday, April 29th. Bank of America lifted their price target on McKesson from $755.00 to $800.00 and gave the company a "buy" rating in a research note on Friday, May 9th. Morgan Stanley increased their price objective on McKesson from $642.00 to $745.00 and gave the stock an "overweight" rating in a research report on Wednesday, April 2nd. Mizuho boosted their target price on shares of McKesson from $630.00 to $690.00 and gave the stock a "neutral" rating in a research report on Thursday, April 3rd. Finally, Evercore ISI upped their target price on shares of McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research report on Thursday, February 6th. Three research analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $686.69.

Insider Buying and Selling

In other news, CFO Britt J. Vitalone sold 1,878 shares of the business's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $717.91, for a total transaction of $1,348,234.98. Following the completion of the sale, the chief financial officer now owns 14,028 shares in the company, valued at $10,070,841.48. The trade was a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, EVP Leann B. Smith sold 1,248 shares of the firm's stock in a transaction dated Thursday, May 22nd. The shares were sold at an average price of $717.30, for a total transaction of $895,190.40. Following the transaction, the executive vice president now directly owns 2,621 shares in the company, valued at $1,880,043.30. The trade was a 32.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 10,856 shares of company stock worth $7,793,675 in the last ninety days. Company insiders own 0.11% of the company's stock.

McKesson Stock Performance

McKesson stock traded up $0.14 on Thursday, reaching $712.27. The company's stock had a trading volume of 506,747 shares, compared to its average volume of 915,369. McKesson Co. has a twelve month low of $464.42 and a twelve month high of $731.00. The company has a market cap of $89.11 billion, a price-to-earnings ratio of 32.61, a PEG ratio of 1.29 and a beta of 0.53. The business's fifty day moving average price is $693.02 and its 200 day moving average price is $636.30.

McKesson (NYSE:MCK - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $10.12 EPS for the quarter, beating analysts' consensus estimates of $9.83 by $0.29. The business had revenue of $90.82 billion during the quarter, compared to the consensus estimate of $94 billion. McKesson had a negative return on equity of 181.26% and a net margin of 0.82%. The firm's revenue was up 18.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $6.18 earnings per share. As a group, equities analysts forecast that McKesson Co. will post 32.77 earnings per share for the current year.

McKesson Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 0.40%. The ex-dividend date of this dividend is Monday, June 2nd. McKesson's dividend payout ratio is 10.99%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.